TrialCancer science2009

Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma.

Kensei Tobinai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.